Market open
LabCorp/$LH
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About LabCorp
Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing.
Ticker
$LH
Sector
Trading on
NYSE
Industry
Health Care Providers & Services
Headquarters
Employees
65,450
Website
LabCorp Metrics
BasicAdvanced
$21B
28.48
$8.67
0.80
$2.88
1.17%
Price and volume
Market cap
$21B
Beta
0.8
52-week high
$258.59
52-week low
$191.97
Average daily volume
911K
Dividend rate
$2.88
Financial strength
Current ratio
1.836
Quick ratio
1.281
Long term debt to equity
76.867
Total debt to equity
79.126
Dividend payout ratio (TTM)
33.20%
Interest coverage (TTM)
5.25%
Management effectiveness
Return on assets (TTM)
4.18%
Return on equity (TTM)
8.98%
Valuation
Price to earnings (TTM)
28.48
Price to revenue (TTM)
1.569
Price to book
2.49
Price to tangible book (TTM)
-12.92
Price to free cash flow (TTM)
17.952
Dividend yield (TTM)
1.17%
Forward dividend yield
1.17%
Growth
Revenue change (TTM)
7.13%
Earnings per share change (TTM)
73.29%
3-year revenue growth (CAGR)
-4.45%
3-year earnings per share growth (CAGR)
-26.46%
What the Analysts think about LabCorp
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for LabCorp stock.
LabCorp Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
LabCorp Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
LabCorp News
AllArticlesVideos

Labcorp Holdings Inc. (LH) Q1 2025 Earnings Call Transcript
Seeking Alpha·7 days ago

Genetic Screening Testing for the Preventive Health Market, 2025-2035 Analysis - Dominated by Exact Science, Labcorp Genetics, Blueprint Genetics, Ambry Genetics, and Genex Diagnostics
GlobeNewsWire·4 weeks ago

Labcorp Holdings: Focus On Core Strengths For Future Growth, Initiate At 'Hold'
Seeking Alpha·3 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Market open
Upcoming events
May29
LabCorp
Dividend·Ex-dividend
Jun11
LabCorp
Dividend·Payment
$0.72
Per share
FAQs
What’s the current market cap for LabCorp stock?
LabCorp (LH) has a market cap of $21B as of May 06, 2025.
What is the P/E ratio for LabCorp stock?
The price to earnings (P/E) ratio for LabCorp (LH) stock is 28.48 as of May 06, 2025.
Does LabCorp stock pay dividends?
Yes, the LabCorp (LH) stock pays dividends to shareholders. As of May 06, 2025, the dividend rate is $2.88 and the yield is 1.17%. LabCorp has a payout ratio of 33.2% on a trailing twelve-month basis.
When is the next LabCorp dividend payment date?
The next LabCorp (LH) dividend payment is scheduled for June 11, 2025.
What is the beta indicator for LabCorp?
LabCorp (LH) has a beta rating of 0.8. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.